Global Vitiligo Market by Countries, Drugs, Companies, Clinical Study, Growth Drivers & Challenges
Global Vitiligo Market Analyst View: Vitiligo is a long-term skin disease in which patches of the skin lose their color. The skin patches affected by the disease Vitiligo become white. This happens because melanocytes within the skin die off. The skin pigmentation, melanin, due to which skin has its color, protection from sun UV rays this all happens because of melanocytes cells. However, shortage of dermatologists and available treatments having longer duration of times are major challenges for the growth of this market. According to Renub Research Global Vitiligo Market will be US$ 2.4 Billion by the year 2024.
Research Report Title: Global Vitiligo Market, Patients By Countries (United States, United Kingdom, France, Germany, Italy, India, China, Japan), Drugs (ARN-4079, ATI-502, AX-1602, BOS-47, CCP070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001) Companies (AXIM Biotechnologies, Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals), Clinical Study, Growth Drivers, Challenges
Get Free Customization in this Report Access Full Research: https://www.renub.com/global-vitiligo-market-p.php
Client can also Order this Report in Sections from the above link
Š Renub Research
Page 1 of 9
www.renub.com